In its latest equity research, Choice Equity Broking has reiterated a 'BUY' recommendation on Tata Consultancy Services (TCS), India’s largest IT services exporter.
Sun Pharmaceutical Industries has received a favorable legal ruling in the United States that clears a key hurdle in launching Leqselvi, its much-anticipated treatment for alopecia areata.
ICICI Securities has maintained a “Buy” rating on Tata Steel, assigning a target price of Rs 180, implying a robust upside potential of 42% from its current level
Motilal Oswal has reiterated a “Buy” recommendation on Tata Consultancy Services (TCS), assigning a target price of Rs 3,850, implying a potential upside of 19%.
Motilal Oswal has initiated coverage on Hindustan Aeronautics Limited (HAL) with a ‘BUY’ rating and a target price of Rs 5,100, implying an upside of 27% from its current market price of Rs 4,031.
In its latest research note, Sharekhan has reiterated a ‘BUY’ call on Tata Consultancy Services (TCS), India's largest IT services provider, despite a softer-than-expected Q4 FY25 performance.
